Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.
Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.
Additionally, Scotiabank maintained its "Sector Outperform" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.